Location: Home
  • search
  • go
  • Relate News
  • 5/15/2025NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...
  • 5/14/2025NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M
  • 5/14/2025Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...
  • 5/14/2025RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...
  • 5/14/2025CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...
  • 5/14/2025R&D Spending Rises at 276 Chinese Drugmakers Despite Revenue Pressures
  • 5/13/2025China Expands Geriatric Services at Major Hospitals as Elderly Populat...
  • 5/12/2025Lepu's Miracogen Launches Phase 3 Trial of Novel EGFR-Targeting ADC Co...
  • 5/12/2025METiS Eyes US$200M Hong Kong IPO as AI Drug Sector Heats Up
  • 5/12/2025Trump's Drug Pricing and the US-China Trade Deal: "Our Interests are D...
  • 5/10/2025~30% of Chinese Listed Pharma Cos Achieve Double Growth in Revenue and...
  • 5/10/2025China's BMI Fund Reports Big Surplus in Q1/2025
  • 5/10/2025Roche Invests Nearly $300M to Build Vabysmo Manufacturing Hub in Shang...
  • 5/10/2025Qilu Secures Greater China Rights to Minghui's B7-H3 ADC in $38M Deal
  • 5/10/2025China's Public Hospitals Grapple with Mounting Debt Amid Reforms and E...
  • 5/10/2025Recent Executive Moves
  • 5/9/202583 Listed Chinese Pharma Firms Top 70% Margins in 2024
  • 5/9/2025China Grants Tariff Exemptions on Select Pharmaceuticals, Microchips, ...
  • 5/9/2025Chinese Biotechs Turn to Switzerland as U.S. Partnerships Waver
  • 5/8/2025Dementia Cases Surge in China at an Unprecedented Rate
  • 5/7/2025Innovent Presents Positive Phase 2 Data for First-in-Class Bispecific ...
  • 5/7/2025Novo Nordisk Sees Surge in China on Wegovy Launch, GLP-1 Momentum
  • 5/7/2025Roche's Columvi Wins Expanded Approval in China for 2L+ DLBCL
  • 5/6/2025China Announces Ambitious Plan to Optimize Primary Healthcare System b...
  • 5/6/2025Immunochina’s IM96 CAR-T Cell Therapy Wins FDA IND Clearance
  • 5/2/2025Recent Executive Moves
  • 5/1/2025AstraZeneca Faces Escalating Legal Challenges in China Over Drug Impor...
  • 5/1/2025CSL Reviews Potential China Tariff Relief for U.S.-Produced Albumin
  • 5/1/2025Pharma's Crossroads: U.S. Investment Surges Under Trump, While China F...
  • 4/30/2025BeiGene Secures Key Patent Victory in Brukinsa Dispute with AbbVie's P...
  • Page:3/359 Total number of articles:10741: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group